A group of bioactive compounds known as triterpenoids, which are often found in plant
materials, have been tested to possess nutritional and pharmaceutical activity. These plant …

A major obstacle in the treatment of tuberculosis (TB) is to combat the emerging resistant
strains of its causing agent ie Mycobacterium tuberculosis (MTb). The emergence of …

The cell wall of Mycobacterium tuberculosis interacts with the host counterpart during the
pathogenesis of tuberculosis. L-rhamnosyl (L-Rha) residue, a linker connects the …

Tuberculosis (TB) is a recurrent and progressive disease, with high mortality rates
worldwide. The drug-resistance phenomenon of Mycobacterium tuberculosis is a major …

Buddleja saligna (family Buddlejaceae) is a medicinal plant endemic to South Africa. Two
isomeric pentacyclic triterpenes, oleanolic acid and ursolic acid, were isolated from the …

Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis (TB), imposes a
significantly high morbidity threat to humans in both developed and developing nations. The …

Tuberculosis (TB) is still one of the world's most challenging infectious diseases and the
emergence of drug-resistant Mycobacterium tuberculosis poses a significant threat to the …

Drug resistance remains one of the primary concerns in treating tuberculosis (TB), making it
imperative to find new and effective drug candidates for improved TB treatment. Enoyl acyl …

Mycobacterial pathogens present a significant challenge to disease control efforts globally
due to their inherent resistance to multiple antibiotics. The rise of drug-resistant strains of …

Candida auris, a pathogenic fungus, has posed significant challenges to conventional
medical treatments due to its increasing resistance to antifungal agents. Consequently, due …